
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 100.930 | 100.930 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.321 | 15.367 |
Price to Book | 3.669 | 2.595 |
Price to Sales | 2.693 | 1.827 |
Price to Cash Flow | 14.072 | 10.099 |
Dividend Yield | 2.683 | 3.457 |
5 Years Earnings Growth | 8.681 | 8.930 |
Name | Net % | Category Average |
---|---|---|
Industrials | 21.690 | 12.318 |
Technology | 21.070 | 14.492 |
Financial Services | 16.030 | 19.488 |
Healthcare | 10.340 | 12.864 |
Consumer Cyclical | 10.160 | 8.831 |
Utilities | 5.050 | 5.855 |
Energy | 3.700 | 5.724 |
Communication Services | 3.570 | 6.432 |
Real Estate | 3.090 | 3.583 |
Consumer Defensive | 2.720 | 12.006 |
Basic Materials | 2.570 | 3.881 |
Number of long holdings: 43
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 5.46 | 472.75 | +0.50% | |
Broadcom | US11135F1012 | 4.59 | 244.28 | -1.07% | |
Merck&Co | US58933Y1055 | 4.15 | 79.33 | +0.46% | |
Siemens AG | DE0007236101 | 3.57 | 219.30 | +0.23% | |
Taiwan Semiconductor | US8740391003 | 3.46 | 206.97 | +0.87% | |
CME Group | US12572Q1058 | 3.44 | 268.35 | -2.15% | |
Novo Nordisk B | DK0062498333 | 3.27 | 490.4 | +2.87% | |
Digital | US2538681030 | 3.12 | 176.68 | -0.09% | |
Intermediate Capital | GB00BYT1DJ19 | 3.10 | 2,024.00 | +0.50% | |
Next | GB0032089863 | 3.06 | 12,840.0 | -0.54% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Mirabaud Eq Glbl Focus A CHF Acc | 191.55M | -11.71 | -1.57 | 3.88 | ||
Mirabaud Glbl Eq HiIncome A CHF Acc | 68.3M | -8.94 | 0.04 | 3.72 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review